Literature DB >> 2646365

Glucose and insulin metabolism in cirrhosis.

A S Petrides1, R A DeFronzo.   

Abstract

Glucose intolerance, overt diabetes mellitus, and insulin resistance are characteristic features of patients with cirrhosis. Insulin secretion, although increased in absolute terms, is insufficient to offset the presence of insulin resistance. The defect in insulin-mediated glucose disposal involves peripheral tissues, primarily muscle, and most likely reflects a disturbance in glycogen synthesis. Hepatic glucose production is normally sensitive to insulin; at present, it is unknown whether hepatic glucose uptake is impaired in cirrhosis. One of the more likely candidates responsible for the insulin-resistant state is insulin itself. The hyperinsulinemia results from three abnormalities: diminished hepatic extraction, portosystemic/intrahepatic shunting, and enhanced insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646365     DOI: 10.1016/0168-8278(89)90169-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Pancreaticoduodenal transplantation with portal venous and enteric drainage in rats.

Authors:  Yong-Ping Gu; Jian-Yun Gu; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.

Authors:  Reona Morio; Hideyuki Hyogo; Masahiro Hatooka; Kei Morio; Hiromi Kan; Tomoki Kobayashi; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Hidenori Ochi; Yoneda Masayasu; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2016-06-28       Impact factor: 7.527

3.  The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population.

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira; Saman Nikeghbalian
Journal:  Mol Biol Rep       Date:  2011-06-25       Impact factor: 2.316

4.  Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Authors:  N Tanabe; M Ishii; Y Sato; T Akahane; N Kobayashi; H Gama; T Iwasaki; T Toyota
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 5.  Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

6.  Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Authors:  Tsuyoshi Ishikawa; Shogo Shiratsuki; Takashi Matsuda; Takuya Iwamoto; Taro Takami; Koichi Uchida; Shuji Terai; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2013-10-05       Impact factor: 7.527

7.  Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

Authors:  Jonathan Montomoli; Peter Holland-Fischer; Giampaolo Bianchi; Henning Grønbaek; Hendrik Vilstrup; Giulio Marchesini; Marco Zoli
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 8.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

9.  The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs.

Authors:  J Radziuk; P Barron; H Najm; J Davies
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.